This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson, is a leading pharmaceutical company headquartered in Belgium (BE). Founded in 1953, Janssen has established itself as a key player in the global healthcare industry, focusing on innovative solutions across various therapeutic areas, including oncology, immunology, neuroscience, and infectious diseases. With a strong presence in Europe, North America, and Asia, Janssen is renowned for its commitment to research and development, delivering unique products that address unmet medical needs. Notable achievements include the development of groundbreaking treatments that have transformed patient care. Janssen's dedication to advancing healthcare through science and innovation solidifies its position as a trusted leader in the pharmaceutical sector.
DitchCarbon Score
How does Janssen Pharmaceutica NV's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Janssen Pharmaceutica NV's score of 81 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Janssen Pharmaceutica NV, headquartered in Belgium (BE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Johnson & Johnson, and as such, it inherits emissions data and climate commitments from its parent organisation. While no specific reduction targets or achievements are listed for Janssen Pharmaceutica NV, it follows the sustainability initiatives set forth by Johnson & Johnson. This includes commitments to the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all of which are cascaded down from Johnson & Johnson. These initiatives aim to significantly reduce greenhouse gas emissions across various scopes, including Scope 1, 2, and 3 emissions. As part of its corporate family, Janssen Pharmaceutica NV aligns with Johnson & Johnson's broader climate strategies, which focus on achieving net-zero emissions and enhancing sustainability practices across its operations. However, specific metrics or targets for Janssen Pharmaceutica NV are not detailed in the available data.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Janssen Pharmaceutica NV is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
